| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191222 | Annals of Allergy, Asthma & Immunology | 2015 | 6 Pages |
Abstract
The high positive predictive value suggests that patients identified using the algorithm are highly likely to have CIU/CSU. The 71.1% sensitivity suggests that most patients with CIU/CSU will be identified. The validation statistics support the use of the diagnosis-based algorithm in claims-based research, although future studies could refine the algorithm further.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Dasha PhD, Karina BPharm, MS, Eunice PhD, Marianne MSc, James L. PhD, MPH, Paul G. MD, Bruce MD, Iftikhar MD, Syed Maseeh MD, Nada MBBS, CRC, Stephen A. MD, Michael S. MD, MSHS,